NICIS-America is a two-day conference that provides a selective overview of cutting edge research in genetics on precision medicinein neurocritical care and stroke. Speakers include thought leaders of neurological disease, proteomics, microbiome analysis, multimodality monitoring, brain mapping, molecular, neuroimaging, mathematical modeling, machine learning, and advanced clinical trial design.
The conference is designed for an interdisciplinary audience of clinicians and researchers with an interest in neurological injury and stroke. This includes intensivists, neurointensivists, neurologists, neurosurgeons, neuroanesthesiologists, neuroradiologists, physiatrists, psychiatrists, neuropsychologists.
The Neuroscience in Intensive Care International Symposium in America (NICIS-America) builds on a highly successful conference and networking event held annually in Paris since 2010 (www.nicis.fr). The vision of NICIS is to provide a forum that will promote transformative advances in the care and science of patients with critical neurological illness and injury. NICIS brings together clinicians and scientists who share a common interest in translating discoveries in the neurosciences into better patient-centered outcomes.
This year's conference is devoted to the theme of Precision Medicine for Neurocritical Care and Stroke. Advances in genetics and in image-guided therapy are already leading to major changes in the classification, management and outcomes of patients with ischemic stroke. New management paradigms are being actively explored in the domains of acute neurological injury—intracerebral hemorrhage, subarachnoid hemorrhage, anoxic-ischemic brain injury, traumatic brain injury. However, more effective predictive modeling and treatment strategies are desperately needed in these populations.